UM

Browse/Search Results:  1-7 of 7 Help

Selected(0)Clear Items/Page:    Sort:
Exploring the immunometabolic potential of Danggui Buxue Decoction for the treatment of IBD-related colorectal cancer Journal article
Zhang, Yang, Kang, Qianming, He, Luying, Chan, Ka Iong, Gu, Hui, Xue, Wenjing, Zhong, Zhangfeng, Tan, Wen. Exploring the immunometabolic potential of Danggui Buxue Decoction for the treatment of IBD-related colorectal cancer[J]. Chinese Medicine (United Kingdom), 2024, 19(1), 117.
Authors:  Zhang, Yang;  Kang, Qianming;  He, Luying;  Chan, Ka Iong;  Gu, Hui; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:5.3/5.5 | Submit date:2024/10/10
Angelicae Sinensis Radix  Astragali Radix  Danggui Buxue Decoction  Ibd-crc  Immunometabolism  
Exploring the immunometabolic potential of Danggui Buxue Decoction for the treatment of IBD-related colorectal cancer Journal article
Zhang Yang, Kang Qianming, Chan Ka Iong, Gu Hui, Xue Wenjing, Zhong Zhangfeng, Tan Wen. Exploring the immunometabolic potential of Danggui Buxue Decoction for the treatment of IBD-related colorectal cancer[J]. Chinese Medicine, 2024.
Authors:  Zhang Yang;  Kang Qianming;  Chan Ka Iong;  Gu Hui;  Xue Wenjing; et al.
Favorite |   IF:5.3/5.5 | Submit date:2024/08/28
Anti-inflammatory effects of natural products from vitamin C-rich fruits Journal article
Chan Sioi, Xiong Ping, Zhao Min, Zhang Siyuan, Zheng Rongbo, Ye Jizeng, Chan Ka Iong, Li Chuyuan, Zhong Zhangfeng. Anti-inflammatory effects of natural products from vitamin C-rich fruits[J]. Food Frontiers, 2024.
Authors:  Chan Sioi;  Xiong Ping;  Zhao Min;  Zhang Siyuan;  Zheng Rongbo; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0 | Submit date:2024/08/28
Gut Microbiota  Inflammation  Machine Learning  Natural Product  Vitamin c  
MYC Oncogene: A Druggable Target for Treating Cancers with Natural Products Journal article
Chan, Ka Iong, Zhang, Siyuan, Li, Guodong, Xu, Yida, Cui, Liao, Wang, Yitao, Su, Huanxing, Tan, Wen, Zhong, Zhangfeng. MYC Oncogene: A Druggable Target for Treating Cancers with Natural Products[J]. Aging and Disease, 2024, 15(2), 640-697.
Authors:  Chan, Ka Iong;  Zhang, Siyuan;  Li, Guodong;  Xu, Yida;  Cui, Liao; et al.
Favorite | TC[WOS]:14 TC[Scopus]:11  IF:7.0/7.1 | Submit date:2023/08/31
Myc  Cancer  Immune Response  Multidrug Resistance  Natural Product  Herbal Medicine  
The immunomodulatory role of matrix metalloproteinases in colitis-associated cancer Journal article
He,Luying, Kang,Qianming, Chan,Ka Iong, Zhang,Yang, Zhong,Zhangfeng, Tan,Wen. The immunomodulatory role of matrix metalloproteinases in colitis-associated cancer[J]. Frontiers in Immunology, 2023, 13.
Authors:  He,Luying;  Kang,Qianming;  Chan,Ka Iong;  Zhang,Yang;  Zhong,Zhangfeng; et al.
Favorite | TC[WOS]:34 TC[Scopus]:38  IF:5.7/6.8 | Submit date:2023/08/03
Colitis Associated Cancer (Cac)  Extracellular Matrix (Ecm)  Immunomodulation  Inflammation  Matrix Metalloproteinases (Mmps)  
Novel Anti-Cancer Products Targeting AMPK: Natural Herbal Medicine against Breast Cancer Journal article
Peng, Bo, Zhang, Siyuan, Chan, Ka Iong, Zhong, Zhangfeng, Wang, Yitao. Novel Anti-Cancer Products Targeting AMPK: Natural Herbal Medicine against Breast Cancer[J]. Molecules, 2023, 28(2), 740.
Authors:  Peng, Bo;  Zhang, Siyuan;  Chan, Ka Iong;  Zhong, Zhangfeng;  Wang, Yitao
Favorite | TC[WOS]:14 TC[Scopus]:16  IF:4.2/4.6 | Submit date:2023/02/08
Ampk  Breast Cancer  Immunity  Metabolism  Metastasis  Multidrug Resistance  Natural Products  
A novel combination treatment of antiADAM17 antibody and erlotinib to overcome acquired drug resistance in non-small cell lung cancer through the FOXO3a/FOXM1 axis Journal article
Li, Junnan, Chen, Pengchen, Wu, Qiushuang, Guo, Libin, Leong, Ka Weng, Chan, Kin Iong, Kwok, Hang Fai. A novel combination treatment of antiADAM17 antibody and erlotinib to overcome acquired drug resistance in non-small cell lung cancer through the FOXO3a/FOXM1 axis[J]. Cellular and Molecular Life Sciences, 2022, 79(12), 614.
Authors:  Li, Junnan;  Chen, Pengchen;  Wu, Qiushuang;  Guo, Libin;  Leong, Ka Weng; et al.
Favorite | TC[WOS]:7 TC[Scopus]:6  IF:6.2/7.7 | Submit date:2023/01/30
Antibody Therapy  Cell Death  Drug Target  Precision Oncology  Small Molecule